World Health Organization Says No To Delayed Disclosure Of Clinical Trials
This article was originally published in The Gray Sheet
Executive Summary
The World Health Organization has decided that the public's need for transparency in clinical trials trumps industry concerns that early disclosure of certain information could undercut a company's competitive advantage
You may also be interested in...
Public Registration Of Device Trials Increases 10-Fold In Two Years
Registration of medical device trials on a government Web site increased more than 10-fold in the past two years, and legislation moving through Congress is likely to expand that activity even further
Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking
Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.